iLiver application

iLiver is an interactive and dynamic app designed for professional use. It delivers instant medical information and clinical recommendations to medical experts (i.e. hepatologists, gastro-enterologists and internal medicine specialists).

The app contains rigorously reviewed and updated information specifically related to liver diseases and can be used on iPhone, iPad and Android devices. It was developed in 2012 by EASL.

Download the app for FREE at the Apple Store or Google™ play

iLiver features the following diseases:

  • A1ATD
  • Acute Liver Failure
  • Alcoholic Liver Disease
  • Ascites
  • Autoimmune Hepatitis
  • Budd-Chiari Syndrome
  • Cholestasis - PBC & PSC
  • Drug-Induced Liver Injury
  • Extra-Hepatic Portal Vein Thrombosis
  • Gallstones
  • Haemochromatosis
  • Hepatic Encephalopathy
  • Hepatitis A
  • Hepatitis B/Hepatitis D
  • Hepatitis C
  • Hepatitis E
  • Hepatocellular Carcinoma
  • Hepatorenal Syndrome
  • Infections in Cirrhosis
  • Liver Diseases in Pregnancy
  • Liver Transplantation
  • Non-Alcoholic Steatohepatitis
  • Non-HCC Liver Tumours
  • Paediatrics Liver Disease
  • Portal Hypertension
  • Wilson's Disease

iLiver is a free application running on iPhone/iPad (iOS 4 required) and Android 2.3 or greater.

Questions, feedback on the app, installation problems? See the iLiver FAQ or send us an email:

Special thanks to the iLiver Contributors

View legal disclaimer.

iLiver by EASL

Dr Ramón Bataller and Prof. Francesco Negro launched the iLiver during the International Liver Congress™ April 18-22, 2012, in Barcelona, Spain.

iLiver launch teaser shown on Thursday 19th at the International Liver Congress™ 2012, in Barcelona, Spain.

Document to download

User guide: how to uninstall iliver and re-install the latest version (484.19 kb)
EASL Premium Sponsors

The following support all EASL activities and programmes throughout the year providing funding for Schools of Hepatology, Fellowships, Bursaries, Monothematic Conferences, Special Conferences, Webcasting, e-Series and the EASL EU Framework Programme.